Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  82,315 results for ""Ifosfamide""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Metaplastic breast cancer: Experience with ifosfamide based chemotherapy.

  • Authors : Gupta N; Department of Radiotherapy and Oncology, Government Medical College and Hospital, Chandigarh, India. Electronic address: .; Dogra S

Subjects: Ifosfamide*/Ifosfamide*/Ifosfamide*/administration & dosage ; Ifosfamide*/Ifosfamide*/Ifosfamide*/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use

  • Source: Current problems in cancer [Curr Probl Cancer] 2024 Dec; Vol. 53, pp. 101148. Date of Electronic Publication: 2024 Sep 21.Publisher: Mosby Country of Publication: United States NLM ID: 7702986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-6345

Record details

Read More Add to Saved list
×
Academic Journal

Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial.

Subjects: Etoposide*/Etoposide*/Etoposide*/administration & dosage ; Etoposide*/Etoposide*/Etoposide*/adverse effects ; Ifosfamide*/Ifosfamide*/Ifosfamide*/administration & dosage

  • Source: JAMA oncology [JAMA Oncol] 2024 Dec 01; Vol. 10 (12), pp. 1645-1653.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure.

  • Authors : Leong M; Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Dai T

Subjects: Nephritis, Interstitial*/Nephritis, Interstitial*/Nephritis, Interstitial*/chemically induced ; Nephritis, Interstitial*/Nephritis, Interstitial*/Nephritis, Interstitial*/genetics ; Ifosfamide*/Ifosfamide*/Ifosfamide*/adverse effects

  • Source: BMC nephrology [BMC Nephrol] 2024 Nov 14; Vol. 25 (1), pp. 409. Date of Electronic Publication: 2024 Nov 14.Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369

Record details

Read More Add to Saved list
×
Academic Journal

Reversible ifosfamide-induced encephalopathy with bursts of triphasic waves responsive to levetiracetam.

  • Authors : Zubko LEBM; Universidade Federal do Paraná, Complexo Hospital de Clínicas, Departamento de Neurologia, Curitiba PR, Brazil.; Brandão LA

Subjects: Levetiracetam*/Levetiracetam*/Levetiracetam*/therapeutic use ; Anticonvulsants*/Anticonvulsants*/Anticonvulsants*/adverse effects ; Anticonvulsants*/Anticonvulsants*/Anticonvulsants*/therapeutic use

  • Source: Arquivos de neuro-psiquiatria [Arq Neuropsiquiatr] 2024 Nov; Vol. 82 (11), pp. 1-3. Date of Electronic Publication: 2024 Sep 02.Publisher: Thieme Country of Publication: Germany NLM ID: 0125444 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1678-4227

Record details

Read More Add to Saved list
×
Academic Journal

Outcome of Relapsed or Refractory Diffuse Large B-cell Lymphoma with Second-line Chemotherapy Ifosfamide-Carboplatin-Etoposide with or without Rituximab.

  • Authors : Haque S; Dr Salina Haque, Assistant Professor, Department of Haematology, National Institute of Cancer Research and Hospital (NICR&H), Dhaka, Bangladesh; E-mail: .

Subjects: Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/mortality ; Etoposide*/Etoposide*/Etoposide*/administration & dosage

  • Source: Mymensingh medical journal : MMJ [Mymensingh Med J] 2024 Oct; Vol. 33 (4), pp. 1176-1183.Publisher: Mymensingh Medical College Country of Publication: Bangladesh NLM ID: 9601799 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Novel strategies in HPV‑16‑related cervical cancer treatment: An in vitro study of combined siRNA-E5 with oxaliplatin and ifosfamide chemotherapy.

  • Authors : Rasizadeh R; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Subjects: Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/drug therapy ; Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/genetics ; Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/virology

  • Source: Gene [Gene] 2025 Jan 10; Vol. 932, pp. 148904. Date of Electronic Publication: 2024 Aug 30.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Paclitaxel-Ifosfamide-based Therapy as Salvage Treatment in Platinum-resistant Recurrent/Metastatic Head and Neck Cancer.

  • Authors : Chou MY; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.; Wu WC

Subjects: Salvage Therapy* ; Head and Neck Neoplasms*/Head and Neck Neoplasms*/Head and Neck Neoplasms*/drug therapy ; Head and Neck Neoplasms*/Head and Neck Neoplasms*/Head and Neck Neoplasms*/pathology

  • Source: In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 1891-1899.Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

A simulated trial with reinforcement learning for the efficacy of Irinotecan and Ifosfamide versus Topotecan in relapsed, extensive stage small cell lung cancer.

  • Authors : Bozcuk HŞ; Medical Oncologist, Private Oncology Practice, Antalya, Turkey. .; Artaç M

Subjects: Topotecan*/Topotecan*/Topotecan*/administration & dosage ; Topotecan*/Topotecan*/Topotecan*/therapeutic use ; Small Cell Lung Carcinoma*/Small Cell Lung Carcinoma*/Small Cell Lung Carcinoma*/drug therapy

  • Source: BMC cancer [BMC Cancer] 2024 Sep 30; Vol. 24 (1), pp. 1207. Date of Electronic Publication: 2024 Sep 30.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Connect Read More Add to Saved list
×
Academic Journal

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease.

  • Authors : Gleeson JP; Cancer Research @UCC, College of Medicine and Health, University College Cork, Cork, Ireland.; Medical Oncology Department, Cork University Hospital, Cork, Ireland.

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Cisplatin*/Cisplatin*/Cisplatin*/administration & dosage

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 10; Vol. 42 (26), pp. 3130-3139. Date of Electronic Publication: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single-arm, exploratory phase II trial.

  • Authors : Tang Q; Department of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.

Subjects: Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/drug therapy ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/mortality ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/therapy

  • Source: Cancer medicine [Cancer Med] 2024 Sep; Vol. 13 (18), pp. e70206.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  82,315 results for ""Ifosfamide""